Orthofix Medical Inc
NASDAQ:OFIX
Orthofix Medical Inc
NASDAQ:OFIX
Price:
15.11 USD
-1.69%
Market Closed
Updated:
May 17, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-13.4
Current
14.8
Median
12.9
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-13.4
Enterprise Value
/
671.7m
EBITDA
-50.2m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
565.3m USD | -13.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.4B USD | 19.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
140.6B USD | 58.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.2B USD | 24.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.9B USD | 14.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.6B USD | 31.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.4B USD | 18.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
60.6B EUR | 19.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54.2B USD | 27.9 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
371.6B CNY | 28.1 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
52.2B USD | 61.1 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
hidden
2-Years Forward
EV/EBITDA
hidden
3-Years Forward
EV/EBITDA
hidden
You don't have any saved screeners yet
